CFO SpotlightsCareers of chief financial officers, from the filings. Records as of October 28, 2026
  1. CFO Spotlights
  2. Profiles
  3. Svai Sanford

Profile

Svai Sanford

Chief Financial Officer (Principal Financial and Accounting Officer), Rani Therapeutics Holdings, Inc.

Former. First published here October 28, 2026; built from records as of October 28, 2026.

Rani Therapeutics Holdings, Inc. named Nicholas M. Maestas to succeed Svai Sanford, effective June 29, 2026.2

Seats

The seat in the record

CompanyTitle as filedStandingFilings
Rani Therapeutics Holdings, Inc. (RANI)
Pharmaceutical Preparations
Chief Financial Officer (Principal Financial and Accounting Officer)Former2

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

  1. June 29, 2026effective

    Rani Therapeutics Holdings, Inc. named Nicholas M. Maestas to succeed Svai Sanford, effective June 29, 2026. Profile of Nicholas M. Maestas.

    [2] Filing by Rani Therapeutics Holdings, Inc., filed with the SEC on June 30, 2026. Read the filing. The record at CFO Tribune.

  2. March 26, 202610-K filed

    Svai Sanford signed the annual report of Rani Therapeutics Holdings, Inc. on Form 10-K as Chief Financial Officer (Principal Financial and Accounting Officer), filed March 26, 2026.

    /s/ Svai Sanford Chief Financial Officer March 26, 2026 Svai Sanford (Principal Financial and Accounting Officer)

    [1] Annual report on Form 10-K by Rani Therapeutics Holdings, Inc., filed with the SEC on March 26, 2026. Read the filing. The record at CFO Tribune.

Sources

Sources

  1. Annual report on Form 10-K, Rani Therapeutics Holdings, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed March 26, 2026. sec.gov; record.
  2. Current report filed with the SEC, Rani Therapeutics Holdings, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed June 30, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Svai Sanford wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.